Does Politico Know Who Kamala Harris Is?

The vice president got high-quality medical care because she’s the goddamn vice president.

This is Kamala Harris. She is being sworn in as Vice President of the United States of America.Saul Loeb/Zuma

The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to the Mother Jones Daily newsletter.

Vice President Kamala Harris tested positive for Covid on Tuesday, and Politico wants to know why she is receiving top-of-the-line health care to treat it. Yesterday’s “West Wing Playbook” newsletter dedicated many paragraphs to pondering medical ethics and why Harris is taking Paxlovid, a highly effective new retroviral medication for Covid-19. But a good answer is only six words long: BECAUSE SHE IS THE VICE PRESIDENT!

Harris is the next in line to run the most powerful country in the world. She is also infected with a virus that can cause short and longterm illness, even in people who are healthy and vaccinated. So why wouldn’t she and her doctors take all possible precautions? Paxlovid is available with a prescription from a doctor for those at high risk of developing a severe case of Covid-19. Is the vice president an obese, diabetic octogenarian? No, but neither is she a 25-year-old athlete. Most importantly, she needs to be able to run the country at a moment’s notice. 

Still, Politico wants to know “Why did Kamala take the Pfizer pill?” even though she is, as far as we know, asymptomatic. The newsletter quotes doctors who question the prescription:

“Why,” asked JONATHAN REINER, professor of medicine and surgery at George Washington University School of Medicine & Health Sciences, “would you give Paxlovid to someone without symptoms?”

Um, perhaps because she is the vice president?

Politico also contrasts Harris’ speedy access to Paxlovid with the difficulty many ordinary Americans have had accessing it: 

…medical ethicists argued that the moral rationalization for giving Harris the medication only underscores how unfair the system is.

“It’s what I make of the American health care system—better to be rich and connected,” said ARTHUR CAPLAN, a New York University professor of medical ethics.

Harris’ speedy access to Paxlovid sharply contrasts with the rest of the country’s ability to get it. The sheer logistics of finagling a prescription, and then finding the pills within days of symptom onset, has complicated the drug’s rollout after it was first authorized in December.

Yes, some people still have trouble getting Paxlovid. Yes, health care is better for the rich. Does that mean the vice president should not receive high-quality medical care? No—because she is the vice president. 

The newsletter did also quote Céline Gounder, a doctor who advised President Joe Biden’s transition team on Covid-19. Grounder, a practicing physician and epidemiologist, pointed out that Harris does indeed qualify for Paxlovid and that sometimes world leaders get good medical care for a reason. “It’s about what’s best for the nation,” she said.

That is the correct answer. Why are we even questioning this?

WE'LL BE BLUNT.

We have a considerable $390,000 gap in our online fundraising budget that we have to close by June 30. There is no wiggle room, we've already cut everything we can, and we urgently need more readers to pitch in—especially from this specific blurb you're reading right now.

We'll also be quite transparent and level-headed with you about this.

In "News Never Pays," our fearless CEO, Monika Bauerlein, connects the dots on several concerning media trends that, taken together, expose the fallacy behind the tragic state of journalism right now: That the marketplace will take care of providing the free and independent press citizens in a democracy need, and the Next New Thing to invest millions in will fix the problem. Bottom line: Journalism that serves the people needs the support of the people. That's the Next New Thing.

And it's what MoJo and our community of readers have been doing for 47 years now.

But staying afloat is harder than ever.

In "This Is Not a Crisis. It's The New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, why this moment is particularly urgent, and how we can best communicate that without screaming OMG PLEASE HELP over and over. We also touch on our history and how our nonprofit model makes Mother Jones different than most of the news out there: Letting us go deep, focus on underreported beats, and bring unique perspectives to the day's news.

You're here for reporting like that, not fundraising, but one cannot exist without the other, and it's vitally important that we hit our intimidating $390,000 number in online donations by June 30.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. It's going to be a nail-biter, and we really need to see donations from this specific ask coming in strong if we're going to get there.

payment methods

WE'LL BE BLUNT.

We have a considerable $390,000 gap in our online fundraising budget that we have to close by June 30. There is no wiggle room, we've already cut everything we can, and we urgently need more readers to pitch in—especially from this specific blurb you're reading right now.

We'll also be quite transparent and level-headed with you about this.

In "News Never Pays," our fearless CEO, Monika Bauerlein, connects the dots on several concerning media trends that, taken together, expose the fallacy behind the tragic state of journalism right now: That the marketplace will take care of providing the free and independent press citizens in a democracy need, and the Next New Thing to invest millions in will fix the problem. Bottom line: Journalism that serves the people needs the support of the people. That's the Next New Thing.

And it's what MoJo and our community of readers have been doing for 47 years now.

But staying afloat is harder than ever.

In "This Is Not a Crisis. It's The New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, why this moment is particularly urgent, and how we can best communicate that without screaming OMG PLEASE HELP over and over. We also touch on our history and how our nonprofit model makes Mother Jones different than most of the news out there: Letting us go deep, focus on underreported beats, and bring unique perspectives to the day's news.

You're here for reporting like that, not fundraising, but one cannot exist without the other, and it's vitally important that we hit our intimidating $390,000 number in online donations by June 30.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. It's going to be a nail-biter, and we really need to see donations from this specific ask coming in strong if we're going to get there.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate